Credit Suisse Ag Nuvasive Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.71 - $44.15 $1.68 Million - $2.02 Million	-45,673 Reduced 30.77%	102,744 $4.27 Million
Q1 2023 May 10, 2023	BUY	$36.81 - $48.12 $2.14 Million - $2.8 Million	58,215 Added 64.54%	148,417 $6.13 Million
Q4 2022 Feb 13, 2023	BUY	$35.68 - $44.71 $523,675 - $656,208	14,677 Added 19.43%	90,202 $3.72 Million
Q3 2022 Nov 10, 2022	BUY	$42.51 - $54.02 $108,187 - $137,480	2,545 Added 3.49%	75,525 $3.31 Million
Q2 2022 Aug 12, 2022	SELL	$46.84 - $59.75 $84,030 - $107,191	-1,794 Reduced 2.4%	72,980 $3.59 Million
Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $72,279 - $86,858	1,503 Added 2.05%	74,774 $4.24 Million
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $169,553 - $225,209	-3,593 Reduced 4.67%	73,271 $3.85 Million
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $202,371 - $241,132	3,556 Added 4.85%	76,864 $4.6 Million
Q2 2021 Aug 16, 2021	SELL	$64.02 - $71.72 $143,916 - $161,226	-2,248 Reduced 2.98%	73,308 $4.97 Million
Q1 2021 May 14, 2021	SELL	$53.26 - $68.08 $1.06 Million - $1.36 Million	-19,959 Reduced 20.9%	75,556 $4.95 Million
Q4 2020 Feb 12, 2021	SELL	$43.41 - $56.51 $4 Million - $5.21 Million	-92,225 Reduced 49.12%	95,515 $5.38 Million
Q3 2020 Nov 13, 2020	BUY	$47.43 - $60.75 $6.07 Million - $7.77 Million	127,944 Added 213.97%	187,740 $9.12 Million
Q2 2020 Aug 12, 2020	BUY	$43.51 - $66.59 $807,980 - $1.24 Million	18,570 Added 45.04%	59,796 $3.33 Million
Q1 2020 May 13, 2020	SELL	$32.82 - $81.13 $113,425 - $280,385	-3,456 Reduced 7.73%	41,226 $2.09 Million
Q4 2019 Feb 12, 2020	BUY	$60.96 - $77.7 $303,154 - $386,402	4,973 Added 12.52%	44,682 $3.46 Million
Q3 2019 Nov 12, 2019	SELL	$55.78 - $68.08 $153,506 - $187,356	-2,752 Reduced 6.48%	39,709 $2.52 Million
Q2 2019 Aug 14, 2019	SELL	$53.69 - $65.47 $567,879 - $692,476	-10,577 Reduced 19.94%	42,461 $2.49 Million
Q1 2019 May 14, 2019	BUY	$44.53 - $58.9 $375,432 - $496,585	8,431 Added 18.9%	53,038 $3.01 Million
Q4 2018 Feb 13, 2019	BUY	$47.64 - $71.26 $71,412 - $106,818	1,499 Added 3.48%	44,607 $2.21 Million
Q3 2018 Nov 13, 2018	SELL	$52.03 - $71.41 $690,386 - $947,539	-13,269 Reduced 23.54%	43,108 $3.06 Million
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $45,742 - $53,846	-950 Reduced 1.66%	56,377 $2.94 Million
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $1.31 Million - $1.74 Million	-28,441 Reduced 33.16%	57,327 $2.99 Million
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $1.78 Million - $2.14 Million	-35,128 Reduced 29.06%	85,768 $5.02 Million
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $2.81 Million - $3.57 Million	52,550 Added 76.89%	120,896 $6.71 Million
Q2 2017 Aug 14, 2017	BUY	N/A	68,346	68,346 $5.26 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account